With over 18 years’ experience in China healthcare industry, Loudon China has built up a robust database. This database covers the incidence of new patients per year and the prevalence of all patients living currently with several key diseases in China.
For a stakeholder to enter into a new therapeutic area or to launch new products or new indications for old products, it is in most situations of key importance to get a comprehensive first-look at any disease and its patients’ dynamics and locations.
Loudon’s databases identify eligible patient populations, disease dynamics and evolution. Product portfolios and city segments can be prioritized, go/no-go criteria defined, competition assessed and unmet needs in the market place identified.

*If any questions, please contact our client service person.
James Th. Loudon
Tel: +86-15221018640
Email: loudon@loudon-research.com
Mark Wagstaff
Tel: +86-13501764474
Email: mark.wagstaff@loudon-research.com
